Obstetrics

OB Hospitalist Group has released data indicating disparities in maternal care because patient race is reduced by care from obstetric hospitalists.

At the 2023 Pediatric Academic Societies meeting, held in Washington, DC, from April 27 to May 1, 2023, the impact that air pollution and climate change has on infants was discussed.

The Supreme Court will make a decision on whether restrictions on mifepristone (Mifeprex; Danco Laboratories) should pass by Friday night.

In a recent study, changes in gestational age distribution in the United States reflected increasing induction of labor rates between 1990 and 2017.

Following voluntary market withdrawal from Covis Pharma, the FDA has decided to withdraw the approval of Makena and its generics for reducing the risk of preterm birth.

For preterm infants, clinical outcomes from microbial mechanisms are not affected by a diet of only human milk compared to bovine milk formulas or fortifiers.

At the 44th National Association of Pediatric Nurse Practitioners Conference, evidence-based approaches for supporting pregnant adolescents were discussed.

There was a lower probability of initiating psycholeptics and having postpartum psychiatric emergencies in the early discontinuer and late discontinuer groups compared to the continuers.

A model to estimate the optimal number of oocytes to try to fertilize during assisted reproductive technology (ART) treatment predicted that 43.4% of oocyte retrievals were day 3 transfers; hence, exposing all oocytes to sperm is recommended.

Nearly 59% of an infant’s microbiota composition is transferred by their mother.

HemaChrom, a digital startup company measuring blood hemoglobin levels with smartphone technology, has won phase 1 of the National Institutes of Health’s RADx Tech for Maternal Health Challenge.

Interventions before and after birth can reduce the rising maternal mortality ratio.

In the editorial featured in the March 2023 issue, Contemporary OB/GYN Editor-in-Chief Catherine Spong, MD, previews the issue's cover story on maternal mortality.

For pregnant women at high risk of preeclampsia, aspirin discontinuation at 24 to 28 weeks’ gestation was comparable to aspirin continuation for preventing preterm preeclampsia, according to recent clinical trial data.

A booster dose of mRNA COVID-19 vaccination during pregnancy increases protection of infants from infection and related hospitalization.

A new study offers insights into future guidelines for certain populations of pregnant women during a national pandemic.

Both undertreatment and overtreatment were common in this cohort of penicillin-allergic pregnant women with Group B Streptococcus (GBS).

Brian Grosberg, MD, and Stephanie Bakaysa, MD, of Hartford HealthCare Medical Group, offered their clinical perspectives on the recently published survey study on management for migraines during pregnancy.

A genome-wide genetic association study using mendelian randomization provides insight into the causal relationships between HDPs and coronary artery disease and ischemic stroke later in life.

In doing so, the country met the new target of the World Health Organization.

Identifying the optimal gestational age with minimal complications for mother and baby has been a topic of long-standing interest.

History, potential value, possible candidates, and limitations of PGT for in vitro fertilization.

In a recent analysis, worse maternal and neonatal outcomes were found when mothers were infected with COVID-19 close to delivery.

An analysis of the HAPO Follow-up Study is shedding light on associations between birth weight categories and risk of diabetes 10-14 years after delivery in mothers.

In the study, investigators analyzed the Jada System in 800 patients from October 2020 to April 2022 across 16 hospitals in the United States. Results of the study were presented at the SMFM 43rd Annual Pregnancy Meeting in San Francisco, California.

A single oral dose of azithromycin in women in labor planning vaginal delivery significantly reduced the risk of maternal death and sepsis, according to study results presented at the SMFM 43rd Annual Pregnancy Meeting.

The clinical psychologist from Ayer Neuroscience Institute at Hartford Healthcare Headache Center shared some highlights from her recently published survey study on migraine treatment during pregnancy.

"Despite advances in SCD management and high-risk pregnancy care, at the national level, outcomes in this population have not improved since the last NIS analysis of data from 1999 to 2008," investigators write.

The rare condition can lead to life-threatening anemia in the fetus and currently lacks FDA-approved treatments.

Majority of women’s health care providers reported in a survey feeling either somewhat or very comfortable with recommending or continuing acute treatments for pregnant patients with migraine.